eurological immune-related adverse events in checkpoint Inhibitor therapy
- Conditions
- neurological (immune-related) adverse Events in checkpoint inhibitor therapy
- Registration Number
- DRKS00019080
- Lead Sponsor
- niversitätsklinikum Essen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
1. patient's consent
2. Age above 18 years
3. sufficient knowledge of German language
4. diagnosis of metastatic melanoma
5. checkpoint Inhibitor therapy
Exclusion Criteria
1. restricted legal capacity
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method occurrence of neurological side effects/ neurological immune related adverse events
- Secondary Outcome Measures
Name Time Method